CBG reduces stress and improves memory in new clinical trial without intoxication

07 Aug 2024 — In a first human clinical trial, cannabigerol (CBG) effectively reduced anxiety and stress without the intoxication typically associated with the whole plant cannabis. In addition, the study indicated some memory-enhancing effects after taking the increasingly popular phytocannabinoid. 

The double-blind, placebo-controlled, experimental trial with 34 healthy cannabis users revealed that 20 mg of hemp-derived CBG significantly reduced feelings of anxiety at 20, 45 and 60 minutes after consumption, compared to a placebo.